Skip to content

Drs. Ghobrial and Nadeem discuss results from the phase II CAR-PRISM trial
FDA approves oral combo for newly diagnosed AML
FDA grants accelerated approval to sonrotoclax for relapsed or refractory mantle cell lymphoma
Gene editing technology may improve toxicity, efficacy of transplants for AML, MDS
5-year BRUIN data show pirtobrutinib induces response in previously treated Waldenström macroglobulinemia

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Elias Jabbour, MD

Cellular Therapy

Elias Jabbour, MD

Leukemia

Elias Jabbour, MD

Lymphoma

Elias Jabbour, MD

Multiple Myeloma

Elias Jabbour, MD

Myelodysplastic Syndromes

Elias Jabbour, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

May 16, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Elias Jabbour, MD

Elias Jabbour, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
587 Views
2 years ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

AACR 2026, Cellular Therapy, Multiple Myeloma, News, Video Interviews

Drs. Ghobrial and Nadeem discuss results from the phase II CAR-PRISM trial

May 15, 2026

FDA laptop

Leukemia, Acute Myeloid Leukemia, News

FDA approves oral combo for newly diagnosed AML

May 14, 2026

Lymphoma, Mantle Cell Lymphoma

FDA grants accelerated approval to sonrotoclax for relapsed or refractory mantle cell lymphoma

May 13, 2026

Acute Myeloid Leukemia, Myelodysplastic Syndromes, News

Gene editing technology may improve toxicity, efficacy of transplants for AML, MDS

May 12, 2026

Indolent B-Cell Lymphomas, News

5-year BRUIN data show pirtobrutinib induces response in previously treated Waldenström macroglobulinemia

May 11, 2026

SOHO 2026, Trending now, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Aggressive B-Cell Lymphomas, Indolent B-Cell Lymphomas, Mantle Cell Lymphoma, T-Cell Lymphoma, News, Society Updates

Submit an abstract for SOHO 2026 by May 15

May 9, 2026

Top Categories

Cellular Therapy

71

Leukemia

110

Lymphoma

122

Multiple Myeloma

94

Myelodysplastic Syndromes

38

Myeloproliferative Neoplasms

22

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Elias Jabbour, MD

Cellular Therapy

Elias Jabbour, MD

Leukemia

Elias Jabbour, MD

Lymphoma

Elias Jabbour, MD

Multiple Myeloma

Elias Jabbour, MD

Myelodysplastic Syndromes

Elias Jabbour, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Drs. Ghobrial and Nadeem discuss results from the phase II CAR-PRISM trial

FDA laptop

FDA approves oral combo for newly diagnosed AML

FDA grants accelerated approval to sonrotoclax for relapsed or refractory mantle cell lymphoma

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.